FOSUN HEALTH Logo

Recurrent Miscarriage Diagnosis

catalogue

Recurrent Miscarriage Diagnosis

Recurrent Miscarriage Diagnosis

The assessment is not a search for who is responsible and it is not an open-ended hunt for a cause that may not exist. It is a bounded set of questions, each attached to something that could be done differently if the answer came back a particular way. Four of them carry most of the weight: whether either parent carries a chromosomal rearrangement, whether the uterus can hold a pregnancy, whether antiphospholipid syndrome is present, and whether thyroid function or glucose is out of range. A fifth question — what has already been tested elsewhere — exists so that results are read together rather than repeated, and so that the parts that remain unexplained can be named as such instead of left open. What the assessment is not is a list of everything that has ever been associated with pregnancy loss. Recurrent loss attracts tests that no evidence supports, and each unnecessary test costs money, time and hope while making the plan no clearer. The end point is deliberately defined: a written summary of what was checked, what it showed, and what will be done differently next time.

The assessment belongs to both partners

Recurrent loss is a condition of a couple, and an assessment that examines one of them is incomplete by construction:

  • Half of the identifiable findings involve the male partner or the pregnancy itself. A chromosomal rearrangement carried by the father, for instance, is found by testing the father, and it is not found by testing the mother harder.
  • The history has to be taken from both. Previous surgery, a childhood operation for an undescended testis, a previous pregnancy with another partner, a family history of clotting — each can point somewhere, and each belongs to one of the two people.
  • Attending together changes the decisions taken. Whether to test the tissue of a loss, how soon to try again, how much investigation to complete first — these are joint decisions, and they are made worse by being relayed second-hand.
  • Being investigated is not the same as being suspected. The tests are not a search for fault, and a plan that lets either partner feel accused has already failed at something clinical.

Why this is the first section. A pattern of loss is created by two people and by each individual pregnancy; treating it as a problem carried by the woman leads to the wrong tests being repeated.

Chromosomes: the parents’, and the pregnancy’s

Two different questions live under this heading, and keeping them apart is most of the work:

  • The chromosomes of a single pregnancy. Most early losses are caused by a chromosomal abnormality in that particular pregnancy, arising by chance and unrelated to either parent’s health or behaviour. This is why a single early loss is not investigated as a pattern.
  • A rearrangement carried by a parent. Where one parent carries a balanced rearrangement they are themselves unaffected, but the pregnancies they produce can be unbalanced — and that can repeat. It is found in a small proportion of couples with repeated loss.
  • Why testing the pregnancy tissue helps. Where tissue from a loss can be tested, a result showing a chromosomal abnormality suggests a chance event, while a normal result shifts attention towards the uterus, the clotting picture and the metabolic background.
  • Why the timing is asked about at the time of the loss. Tissue testing is only possible if the arrangements are made when the loss happens, which is why the option is raised in advance rather than afterwards.
  • What a parental result changes. Where a rearrangement is found, the options and their implications are discussed with both partners — including what can be offered in a subsequent pregnancy — rather than presented as a verdict.

Why this is asked about first. It is the explanation most easily heard as an accusation, so the commonest cause — an abnormality in the pregnancy itself — has to be separated from a rearrangement a parent carries.

The uterus: correcting what can be corrected

The cavity is looked at because some of what can be found there can be changed, and an uncorrected finding is discovered at the worst possible moment:

  • Adhesions. Scarring inside the cavity, sometimes following a previous procedure or infection, which can affect a later pregnancy — and which is one reason how a loss is managed matters.
  • A fibroid distorting the cavity. The position matters more than the size: a fibroid that changes the shape of the cavity is a different finding from one that sits in the wall without disturbing it.
  • How the cavity is examined. Ultrasound begins the assessment; where a finding is suspected or needs treatment, hysteroscopy shows the cavity directly and allows correction at the same time.
  • When correction is offered, and when it is not. Surgery is offered where the finding is one that can be corrected and where correcting it plausibly changes what happens next — not simply because something was seen.

Why the cavity is assessed before a pregnancy. A correction takes a healing interval, so it is arranged in advance; found during a pregnancy, nothing is left to do but monitor.

Antiphospholipid syndrome: the treatable cause worth finding

Of everything the assessment looks for, this is the finding with the clearest treatment path, and the one where the testing rules matter most:

  • It is a condition in which the blood is more likely to clot. It can affect a pregnancy through the circulation to the placenta, and it can exist without any other symptom having appeared.
  • The test is repeated, and this is not bureaucracy. Antibodies can appear transiently, and a single positive result does not make the diagnosis. Testing again after the interval the guidelines specify is what separates a real finding from a passing one.
  • Treatment exists and is started before or early in pregnancy. Because there is an intervention that changes what happens, finding this cause is worth the effort — which is precisely the test of whether a test belongs in the assessment.
  • A related history raises the index of suspicion. A previous clot, an autoimmune condition such as lupus, or a family history of clotting makes the antibody tests more likely to be informative.

Why this section is longer than its frequency suggests. The value of a test lies in what it changes, and this is the clearest example in recurrent loss of a result that leads to an action.

Thyroid, glucose and hormone problems that can be controlled

These are not exotic findings. They are common, they are measurable, and they belong to the group that can be corrected before conception:

  • Thyroid function. Both an underactive thyroid and the antibodies associated with it are relevant to early loss, and both are treatable — with the treatment adjusted before conception rather than after.
  • Glucose and diabetes. Poorly controlled glucose is associated with loss, and the preparation is a matter of control achieved in advance rather than of adjustment once a pregnancy has begun.
  • Polycystic ovary syndrome. Relevant through its metabolic and hormonal features, and worth identifying because it changes the preparation rather than only the pregnancy.
  • What control means in practice. The target is a range agreed with the treating team and reviewed before conception, not a single reading taken at one appointment.

Why these are grouped together. They share a property that the chromosomal and uterine findings do not: they can be measured, treated and reviewed before a pregnancy starts. That makes them the part of the preparation most likely to change something.

What is not looked for, and why

A complete assessment is defined as much by what it leaves out as by what it includes, and the omissions are deliberate:

  • Thrombophilia screening is not routine. Inherited clotting tendencies are widely tested for and the evidence that treating them changes the outcome of pregnancy is not there; the exception is a personal or family history that makes the question a different one.
  • Immune treatments are not routine. Several treatments aimed at the immune system have been used widely and are not supported by evidence for unselected recurrent loss, and they carry their own risks.
  • Bed rest is not offered. It has no supporting evidence, does not reduce loss, and increases the risk of clots.
  • Repeating tests that have already been done properly is avoided. Where a result exists and the timing is appropriate, it is used rather than repeated — which is one reason records are collected before the assessment starts.

Why saying no is part of the plan. A couple who have lost several pregnancies will accept almost any test offered, and every test that cannot change what happens next still costs time, money and the impression that something was found.

Frequently Asked Questions

How long does the assessment take?

Most of it completes within one or two menstrual cycles. The history is taken at the first consultation and is the longest part of it. Blood tests are timed to the cycle where that matters, antibody testing needs a repeat after an interval, and imaging of the cavity is arranged around the cycle as well. Where the assessment follows a loss, a short recovery period sits in front of it. The assessment is deliberately finished before another pregnancy rather than running alongside one.

Do we have to repeat tests that were done elsewhere?

Usually not, if the results are documented and the timing is appropriate. Antibody results, thyroid function with the date it was taken, glucose measurements and imaging of the cavity are all usable. What is repeated is anything whose result would change a decision and whose documentation or timing is incomplete. Bringing the existing records in English, or with an English summary, means the first consultation is spent on what the results mean rather than on finding out what they were.

What if the assessment finds nothing at all?

That is the commonest single result, and it is recorded as unexplained rather than left open. In about half of couples a complete assessment finds none of the known causes. What changes is the direction of the plan: towards early monitoring in the next pregnancy, towards honest expectation, and towards support. What it does not mean is that nothing was looked for, and it should never be reported as though the tests had been inconclusive.

Is there anything in the assessment that is urgent?

Only one thing sits outside the ordinary schedule, and it is not part of the assessment itself: bleeding or pain in early pregnancy, particularly one-sided pain or shoulder-tip pain, needs to be seen promptly because a pregnancy outside the uterus has to be excluded. Everything else in this pathway is planned work, and it is arranged around the cycle rather than around urgency.

Patient Stories

Stories from our recurrent miscarriage programme, pulled automatically from the patient story library by disease tag.

View all patient stories →

Send the records that already exist.

Send the account of each pregnancy with its stage and how it was managed, and any results you already have — antibody tests with their dates, thyroid function, glucose, and imaging of the uterus. What comes back is a written view of what the assessment still needs to establish, what the pattern suggests should be looked for first, and the order the tests would follow. Within about 48 hours of complete records arriving.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*